TRMT61A divergent transcript (TRMT61A-DT)

TRMT61A-DT (TRMT61A divergent transcript) refers to a non-coding RNA (RNA gene) located near or transcribed divergently from the TRMT61A gene but does not code for the protein tRNA methyltransferase 61A itself[1]. The canonical functional target is "TRMT61A" (tRNA methyltransferase 61A), which encodes an enzyme subunit involved in N1-methyladenosine modification of tRNA and possibly mRNA – a key step in RNA epigenetic regulation[2][3]. "TRMT61A-DT" does not appear to be a recognized or characterized therapeutic target in the literature or therapeutic databases and there is little or no information describing its molecular function, role in disease, or druggability[1]. It may simply denote the divergent non-coding RNA transcript from the TRMT61A locus, common in lncRNA gene annotation, but not a known protein, receptor, or enzyme target. No specific molecular activities, disease roles, drug interaction, or clear biomarker status have been ascribed to TRMT61A-DT. If you were seeking information on the functionally characterized protein, the correct target is "tRNA methyltransferase 61A" (TRMT61A), which is an enzymatic "writer" responsible for tRNA and mRNA N1-methyladenosine modifications promoting protein translation regulation, cell proliferation, and immune function, with disease implications for cell stress and development[2][3]. However, these functions do not pertain to the "divergent transcript" form. In summary, "TRMT61A divergent transcript" is not a conventional or therapeutic molecular target, nor is it a well-described molecular entity; this makes its use as a "target" likely inaccurate or nonstandard[1].

Other names

TRMT61A-DTTRMT61A divergent transcript